Výsledky vyhledávání - "Atlal M, Abusanad"

Tele-Oncology: An Emerging Technology in Developing Countries during the COVID-19 Pandemic

Autor: Atlal M. Abusanad, Humaid O. Al-Shamsi

Publikováno v: New Emirates Medical Journal. 2:13-15

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::94bae14432e2681e9e690a33cc9e6ed6
https://doi.org/10.2174/0250688201999201109160857

Zobrazit plný text záznamu

The effect of breast radiotherapy parameters (XRT), chemotherapy regimens (CT) and dual anti-HER2 monoclonal antibodies (MoAb) on the development of cardiac dysfunction (CD) among patients with HER2-positive breast cancer from Saudi Arabia

Autor: Atlal M. Abusanad, Omar Iskanderani, Marwan R. Al-hajeili, Reem Ujaimi

Publikováno v: Journal of Clinical Oncology. 40:e12508-e12508

e12508 Background: Treatment with anti-HER2 therapy can cause CD. The effect of breast XRT, heart dose and V25 of the heart and CT regimen on developing CD is controversial. The impact of these variables in developing CD among patients with HER2-posi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bacddbfa158069f7ee68be53ccec7ab9
https://doi.org/10.1200/jco.2022.40.16_suppl.e12508

Zobrazit plný text záznamu

Association between

Autor: Ayat B, Al-Ghafari, Areej M, Al Qahtani, Suzan N, Alturki, Huda A, Al Doghaither, Ekramy M, Elmorsy, Hanaa M, Tashkandi, Atlal M, Abusanad, Shadi S, Alkhayyat, Ulfat M, Omar, Ahmed A, Zeeneldin

Publikováno v: Oncology Letters

Multidrug resistance member 1 (MDR1) is located on chromosome 7 and encodes P-glycoprotein, which is universally accepted as a drug resistance biomarker. MDR1 polymorphisms can alter protein expression or function, which has been previously reported

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e389ff28e75970965b338a71b321a299
https://pubmed.ncbi.nlm.nih.gov/32934723

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání